v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenues
General and administrative costs:        
Compensation to related parties, including stock-based compensation expense of $396,883 and $347,222 for the three months ended September 30, 2022 and 2021, respectively, and $1,160,649 and $1,854,058 for the nine months ended September 30, 2022 and 2021, respectively 643,957 573,472 1,963,409 2,450,641
Patent and licensing legal and filing fees and costs 271,163 137,114 944,789 365,466
Other costs and expenses 290,993 299,953 875,016 946,266
Research and development costs 272,388 227,181 895,649 933,122
Total costs and expenses 1,478,501 1,237,720 4,678,863 4,695,495
Loss from operations (1,478,501) (1,237,720) (4,678,863) (4,695,495)
Interest income 3,911 161 4,211 487
Interest expense (2,119) (5,240) (2,944)
Foreign currency loss (1,300) (1,165) (1,339) (1,082)
Net loss $ (1,478,009) $ (1,238,724) $ (4,681,231) $ (4,699,034)
Net loss per common share – basic and diluted $ (0.09) $ (0.09) $ (0.30) $ (0.35)
Weighted average common shares outstanding – basic and diluted 16,646,593 13,733,912 15,541,831 13,381,922

Source